Core Viewpoint - The proposed change of control at Yonghe Intelligent Control has been abruptly terminated due to the failure of Hangzhou Runfeng to fulfill payment obligations under the share transfer agreement [1][2] Group 1: Share Transfer Agreement - On August 5, a share transfer agreement was signed between Cao Delin and Hangzhou Runfeng, where Cao intended to transfer 35.66 million shares (8% of total shares) at approximately 8.97 yuan per share, totaling 320 million yuan [1] - The agreement included a voting rights delegation agreement, which would have resulted in a change of controlling shareholder from Cao Delin to Sun Rongxiang [1] - The transfer was contingent upon Hangzhou Runfeng making an initial payment of 20.01 million yuan, which was not completed, leading to the automatic invalidation of the agreement [2] Group 2: Company Control and Ownership - As of the announcement date, Cao Delin and his associates held 46.73 million shares, representing 10.49% of the total share capital, indicating that control remains unchanged [2] - The termination of the share transfer agreement ensures that Cao Delin continues as the controlling shareholder and actual controller of Yonghe Intelligent Control [2] Group 3: Company Background and Business Segments - Yonghe Intelligent Control was founded in 2003 and listed on the Shenzhen Stock Exchange in April 2016, initially focusing on fluid control equipment [2] - In 2019, the company expanded into the medical sector with a focus on precision radiation therapy for tumors [2] - In December 2022, Yonghe Intelligent Control became a controlling shareholder of Puluo New Energy Technology (Taixing) Co., Ltd., entering the photovoltaic industry, and currently operates in three main sectors: valves, medical, and photovoltaic [2] Group 4: Financial Performance - The company has projected a net loss of 30 million to 56 million yuan for the first half of 2025, indicating ongoing financial challenges [2]

Core Viewpoint - Yonghe Intelligent Control (002795) is planning a change of control, with its stock price experiencing a strong surge recently [1] Group 1: Share Transfer Agreement - On August 5, Yonghe Intelligent Control announced that its controlling shareholder, Cao Deli, signed a share transfer agreement with Hangzhou Runfeng Intelligent Equipment Co., Ltd., transferring 35.66 million shares (8% of total shares) at approximately 8.97 yuan per share, totaling 320 million yuan [1] - Following the share transfer, the controlling shareholder will change from Cao Deli to Hangzhou Runfeng, and the actual controller will change to Sun Rongxiang [3] - The share transfer does not trigger a mandatory bid and is not considered a related party transaction, pending compliance confirmation from the Shenzhen Stock Exchange [3] Group 2: Previous Control Change Attempt - Two years prior, Yonghe Intelligent Control attempted to transfer control but ultimately failed [3] - In November 2023, Cao Deli signed a share transfer agreement with Guangdong Pule Green Energy Holdings Co., Ltd., proposing to transfer 59.30 million shares (13.3% of total shares) at approximately 8.9736 yuan per share, totaling 532 million yuan [4] - This transaction was later terminated due to significant changes in transaction conditions, with all related agreements being voided [4] Group 3: Company Background and Financial Performance - Yonghe Intelligent Control was founded in 2003 and listed on the Shenzhen Stock Exchange in April 2016, initially focusing on fluid control equipment [5] - The company expanded into medical business related to tumor precision radiation therapy in 2019 and became a controlling shareholder in a photovoltaic company in December 2022 [5] - For the first half of 2025, the company expects a net loss of 30 million to 56 million yuan, attributed to decreased revenue in the valve and pipe fittings business and high depreciation and labor costs, although the net profit attributable to the parent company has increased due to reduced losses in the photovoltaic sector [5]